Combining mTOR inhibition with metronomic chemotherapy in targeting angiogenesis.
Chau
Cindy H
CH
Molecular Pharmacology Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Wang
Weixin
W
Figg
William D
WD